Minimize risk with early-stage analytical method development and validation

The successful launch of a new drug application hinges on your analytical method development. It is vital to establish a clear  understanding of method design and robustness early in the process to minimize risk. Solvias offers comprehensive method development services, guiding you from early-stage to approval and commercialization, balancing cost-efficiency and quality.

Unique combination of benefits

  • Expert-led analytical method development and validation
  • Faster development using platform methods spanning early characterization and development to fully validated late- to commercial-stage QC panels
  • Flexible options for client established methods
  • Focus on quality, speed, and risk mitigation

Comprehensive service solutions

The breadth of our analytical method development portfolio, expert team, and experience equip Solvias to provide a comprehensive CMC program for small molecules, biologics, and cell and gene therapies.

Validated QC methods

Successful molecule dependent methods have been developed for the following techniques:

|

HPLC (IEX, SEC, RP, HIC, HILIC, NP, HPAEC, IC, affinity with UV, FL, RI, ELSD, MALLS and MS detection

CGE (UV, LIF), CGE-SDS (UV, FL, LIF), cIEF (UV, FL, MS), CZE (UV, LIF, MS)

CD, SoloVPE UV, FL, FT-IR, Raman, SEM-EDX NMR, DLS, MALLS, AUC

Osmolarity, density, viscosity (rolling ball, capillary, rheometer) nDSC, visible and subvisible particles (membrane microscopy, light obscuration, flow imaging)

Particle size, specific surface area and porosity, XRPD, bulk and tapped density, DSC, TGA, ITC(TAM), SEM, TEM

APSD (NGI), DDU, droplet size distribution, spray pattern & plume geometry

Intrinsic, extrinsic, UV and HPLC readout, friability

LC-MS (Orbitrap, qTOF, Triple Quad), GC-MS, (Orbitrap, Triple Quad, Single Quad) CE-MS (cIEF-qTOF-MS, CZE-qTOF-MS), Hydrogen-Deuterium-Exchange Mass spectrometry HDX-MS (LEAP-PAL – Orbitrap-MS)

ICP-MS, ICP-OES, AAS, XRF

Cell-based bioassay, ELISA, western blotting, residual DNA (threshold analysis, qPCR), rodent parvoviruses, surface plasmon resonance, RNA and DNA sequencing

Bioburden, endotoxin, sterility, viral safety, cell biology methods and potency assays

decorative roadmap graphic

Contact us for a complimentary consultation